Henderson Jane
Chief Financial Officer
CIK: 1422304
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 1, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 900 | $82.60 | $74,340.00 | View Details Filing |
| May 1, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 289 | $83.16 | $24,033.24 | View Details Filing |
| May 1, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 811 | $81.02 | $65,707.22 | View Details Filing |
| Apr 16, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 2,000 | $90.00 | $180,000.00 | View Details Filing |
| Apr 1, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 900 | $84.46 | $76,014.00 | View Details Filing |
| Apr 1, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 1,100 | $85.46 | $94,006.00 | View Details Filing |
| Mar 25, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 2,000 | $85.00 | $170,000.00 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 300 | $69.43 | $20,829.00 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 406 | $71.66 | $29,093.96 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 994 | $70.45 | $70,027.30 | View Details Filing |
| Mar 2, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 300 | $68.27 | $20,481.00 | View Details Filing |